Cotempla XR-ODT (methylphenidate extended-release orally disintegrating tablets) is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. It is designed to be taken once daily and dissolves quickly in the mouth without the need for water.
How does Cotempla work for ADHD?
Cotempla XR-ODT contains methylphenidate, a central nervous system stimulant. It works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. These neurotransmitters play a role in regulating attention, impulse control, and hyperactivity. By balancing these chemicals, Cotempla XR-ODT helps improve focus and reduce impulsive behaviors associated with ADHD [1].
When does Cotempla XR-ODT patent protection expire?
The patent exclusivity for Cotempla XR-ODT, manufactured by Neos Therapeutics, has expired. This means that generic versions of the drug can now be produced and marketed. Information on specific patent expiry dates for individual drugs, including Cotempla XR-ODT, can be found through resources like DrugPatentWatch.com [2].
Can other companies make generic versions of Cotempla?
With the expiration of its primary patents, other pharmaceutical companies can develop and market generic versions of Cotempla XR-ODT. The availability of generics typically leads to lower drug prices.
What are the side effects of Cotempla XR-ODT?
Common side effects of Cotempla XR-ODT can include decreased appetite, insomnia, weight loss, headache, stomach pain, nausea, anxiety, and irritability. More serious side effects, though less common, may include heart problems, psychiatric symptoms, and circulatory issues. Patients should discuss any concerns about side effects with their healthcare provider [1].
How is Cotempla XR-ODT different from other ADHD medications?
Cotempla XR-ODT's unique feature is its orally disintegrating tablet (ODT) formulation, which allows it to dissolve quickly in the mouth without water. This can be beneficial for children who have difficulty swallowing pills. It also offers extended-release action, meaning it provides symptom control throughout the day with a single daily dose [1]. Other ADHD medications may come in different forms, such as immediate-release tablets, capsules, liquids, or patches, and may contain different active ingredients like amphetamines.
What clinical data supports Cotempla XR-ODT's effectiveness?
Clinical trials have demonstrated the efficacy of Cotempla XR-ODT in improving ADHD symptoms in children and adolescents. These studies typically measure improvements in behavior and attention in controlled settings. Detailed clinical data can be found in the drug's prescribing information and through medical literature databases.
What are the costs and insurance considerations for Cotempla XR-ODT?
The cost of Cotempla XR-ODT can vary depending on the pharmacy, dosage, and insurance coverage. Generic versions, now available, are generally less expensive than the brand-name drug. Insurance plans often provide coverage for ADHD medications, but co-pays and deductibles will apply. Patients should verify their specific coverage with their insurance provider.
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/